Atomistry » Fluorine » PDB 8phl-8q0w » 8pqd
Atomistry »
  Fluorine »
    PDB 8phl-8q0w »
      8pqd »

Fluorine in PDB 8pqd: C-Kit Kinase Domain in Complex with Avapritinib Derivative 10

Enzymatic activity of C-Kit Kinase Domain in Complex with Avapritinib Derivative 10

All present enzymatic activity of C-Kit Kinase Domain in Complex with Avapritinib Derivative 10:
2.7.10.1;

Protein crystallography data

The structure of C-Kit Kinase Domain in Complex with Avapritinib Derivative 10, PDB code: 8pqd was solved by A.Teuber, M.P.Mueller, D.Rauh, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 41.99 / 1.50
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 59.39, 59.37, 192.89, 90, 90, 90
R / Rfree (%) 17.5 / 19.4

Fluorine Binding Sites:

The binding sites of Fluorine atom in the C-Kit Kinase Domain in Complex with Avapritinib Derivative 10 (pdb code 8pqd). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the C-Kit Kinase Domain in Complex with Avapritinib Derivative 10, PDB code: 8pqd:
Jump to Fluorine binding site number: 1; 2;

Fluorine binding site 1 out of 2 in 8pqd

Go back to Fluorine Binding Sites List in 8pqd
Fluorine binding site 1 out of 2 in the C-Kit Kinase Domain in Complex with Avapritinib Derivative 10


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of C-Kit Kinase Domain in Complex with Avapritinib Derivative 10 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F1001

b:26.6
occ:0.69
F35 A:9VV1001 0.0 26.6 0.7
C32 A:9VV1001 1.4 27.7 1.0
C31 A:9VV1001 2.4 25.6 1.0
C33 A:9VV1001 2.4 26.5 0.8
CD2 A:LEU625 3.2 43.0 1.0
O A:MET624 3.4 33.4 1.0
CG A:LEU625 3.4 37.5 1.0
C A:MET624 3.5 32.6 1.0
C30 A:9VV1001 3.6 23.3 1.0
C34 A:9VV1001 3.7 24.3 0.8
CG A:LYS623 3.7 25.3 1.0
N A:LEU625 3.8 30.1 1.0
CE A:LYS623 3.9 29.3 1.0
CA A:LEU625 4.0 34.7 1.0
CD1 A:LEU637 4.0 25.3 1.0
O A:HOH1292 4.1 38.3 1.0
CD2 A:LEU637 4.1 26.7 1.0
N A:MET624 4.1 25.1 1.0
C29 A:9VV1001 4.2 26.2 1.0
CA A:MET624 4.3 26.1 1.0
CB A:LEU625 4.3 32.7 1.0
CD A:LYS623 4.3 26.4 1.0
CG A:LEU637 4.5 24.1 1.0
CD1 A:LEU625 4.6 40.5 1.0
CA A:GLY601 4.7 37.1 1.0
C A:LYS623 4.8 24.9 1.0
CB A:LEU637 4.8 24.9 1.0
O A:PHE600 4.9 53.6 1.0

Fluorine binding site 2 out of 2 in 8pqd

Go back to Fluorine Binding Sites List in 8pqd
Fluorine binding site 2 out of 2 in the C-Kit Kinase Domain in Complex with Avapritinib Derivative 10


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of C-Kit Kinase Domain in Complex with Avapritinib Derivative 10 within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F1001

b:31.0
occ:1.00
F35 B:9VV1001 0.0 31.0 1.0
C32 B:9VV1001 1.4 30.1 1.0
C33 B:9VV1001 2.4 26.4 1.0
C31 B:9VV1001 2.4 26.4 1.0
CD2 B:LEU625 3.2 36.7 1.0
CG B:LEU625 3.3 34.8 1.0
O B:MET624 3.4 26.8 1.0
C B:MET624 3.4 24.6 1.0
C34 B:9VV1001 3.6 28.2 1.0
C30 B:9VV1001 3.7 30.0 1.0
CG B:LYS623 3.7 24.2 1.0
N B:LEU625 3.7 28.6 1.0
CE B:LYS623 3.8 24.1 1.0
CD1 B:LEU637 3.9 26.2 1.0
CD2 B:LEU637 3.9 31.4 1.0
N B:MET624 4.0 22.6 1.0
CA B:LEU625 4.0 31.3 1.0
CA B:MET624 4.1 25.0 1.0
O B:HOH1249 4.1 36.8 1.0
C29 B:9VV1001 4.2 27.2 1.0
CB B:LEU625 4.3 31.2 1.0
CD B:LYS623 4.3 25.0 1.0
CG B:LEU637 4.3 25.6 1.0
CD1 B:LEU625 4.4 40.1 1.0
CA B:GLY601 4.5 30.1 1.0
CB B:LEU637 4.6 28.2 1.0
C B:LYS623 4.6 20.7 1.0
CB B:LYS623 4.9 22.8 1.0

Reference:

A.Teuber, T.Schulz, B.S.Fletcher, R.Gontla, T.Muehlenberg, M.-L.Zischinsky, J.Niggenaber, J.Weisner, S.B.Kleinboelting, J.Lategahn, S.Sievers, M.P.Mueller, S.Bauer, D.Rauh. Avapritinib-Based Sar Studies Reveal A Binding Pocket in Kit and Pdgfra Nat Commun 2023.
ISSN: ESSN 2041-1723
DOI: 10.1038/S41467-023-44376-8
Page generated: Wed Jul 16 06:43:27 2025

Last articles

Mg in 7TJH
Mg in 7TJF
Mg in 7TJA
Mg in 7TII
Mg in 7TIX
Mg in 7TIV
Mg in 7TIU
Mg in 7TIH
Mg in 7TIE
Mg in 7TID
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy